2023 May ACSoMP recommendations

The World Health Organization (WHO)’s Advisory Committee on Safety of Medicinal Products (ACSoMP) is an independent expert advisory body established in 2003 that provides independent, authoritative scientific advice on pharmacovigilance policies and issues related to the safety of medicines to the Director General of WHO and its Member States.

WHO convened a hybrid meeting of ACSoMP from 11 to 12 May 2023, with some members joining in person in Geneva, and others joining online. The sessions were co-chaired by Dr. June Raine from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and Dr. Gerald Dal Pan from the United States Food and Drug Administration (US FDA).